Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Granzyme K in the Pathogenesis of Psoriasis

FY 2018-19

Summary
Psoriasis is a common skin disease characterized by thick, itchy, red patches with a silvery white build-up of dead skin called ‘plaques’. Around one million Canadians are currently living with psoriasis. Although psoriasis is not usually deadly, this chronic condition can seriously impact a person’s overall quality of life, as it is linked with social stigmatization, physical disability, pain, psychological distress and increased health risks. Unfortunately there is no cure, and current therapies often have negative side-effects and fail to provide long term relief. There is therefore a crucial need to further understand how psoriasis arises so that we can develop more effective and better targeted drugs. A family of proteins called granzymes are drastically elevated in a number of inflammatory skin diseases including psoriasis. One granzyme, called granzyme K (GzmK), has recently been shown to promote inflammation in the skin. As our preliminary data suggest that GzmK is elevated in psoriasis, I believe that this inflammation-promoting enzyme could play a key role in the cause of this condition. To understand the role of GzmK in psoriasis, I will use a combination of skin cell, mouse and human models of disease. I will look at the direct effects of GzmK on skin cells and will study the role of GzmK in the causation of psoriasis using a mouse model in which GzmK is genetically removed. Based on our preliminary data, I predict that these studies will show that GzmK plays a key role in psoriasis and will provide a strong rationale for developing new drugs targeting GzmK to treat this disease.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
406474
Name
Richardson Katlyn C
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Granzyme K in the Pathogenesis of Psoriasis
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Granzyme K; Inflammation; Psoriasis; Skin Disease
Abstract
Psoriasis is a common skin disease characterized by thick, itchy, red patches with a silvery white build-up of dead skin called ‘plaques’. Around one million Canadians are currently living with psoriasis. Although psoriasis is not usually deadly, this chronic condition can seriously impact a person’s overall quality of life, as it is linked with social stigmatization, physical disability, pain, psychological distress and increased health risks. Unfortunately there is no cure, and current therapies often have negative side-effects and fail to provide long term relief. There is therefore a crucial need to further understand how psoriasis arises so that we can develop more effective and better targeted drugs. A family of proteins called granzymes are drastically elevated in a number of inflammatory skin diseases including psoriasis. One granzyme, called granzyme K (GzmK), has recently been shown to promote inflammation in the skin. As our preliminary data suggest that GzmK is elevated in psoriasis, I believe that this inflammation-promoting enzyme could play a key role in the cause of this condition. To understand the role of GzmK in psoriasis, I will use a combination of skin cell, mouse and human models of disease. I will look at the direct effects of GzmK on skin cells and will study the role of GzmK in the causation of psoriasis using a mouse model in which GzmK is genetically removed. Based on our preliminary data, I predict that these studies will show that GzmK plays a key role in psoriasis and will provide a strong rationale for developing new drugs targeting GzmK to treat this disease.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Richardson, Katlyn C
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~